Eli Lilly expands $2.75B AI-enabled drug discovery deal with Insilico Medicine

Eli Lilly expands $2.75B AI-enabled drug discovery deal with Insilico Medicine Eli Lilly and Insilico Medicine have announced an expansion in existing collaboration, aiming to boost AI-powered drug discovery. The new deal worth up to $2.75 billion will focus on financial assistance,...

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.